Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Jia Jie Biomedical CoROCO:4109 59 5-Year Yield-on-Cost % is 4.44 as of Sep. 01, 2026, which is 331% above its 10-year median of 1.03. GuruFocus rates ROCO:4109 with a GF Score™ of 59/100 and a GF Value™ of NT$16.00 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,152 Consumer Packaged Goods companies, Jia Jie Biomedical Co ranks better than 61.11% on this metric.
Jia Jie Biomedical Co's yield on cost for the quarter that ended in Jun. 2026 was 4.44.
The historical rank and industry rank for Jia Jie Biomedical Co's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:4109'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.41 Med: 1.03 Max: 4.52
Current: 4.44
During the past 13 years, Jia Jie Biomedical Co's highest Yield on Cost was 4.52. The lowest was 0.41. And the median was 1.03.
ROCO:4109's 5-Year Yield-on-Cost % is ranked better than 61.11% of 1152
companies
in the Consumer Packaged Goods industry
Industry Median: 3.37
vs ROCO:4109: 4.44
Jia Jie Biomedical Co (ROCO:4109) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Jia Jie Biomedical Co 5-Year Yield-on-Cost % Related Terms
ROCO:4109 vs KHC, GIS: 5-Year Yield-on-Cost % Comparison
For the Packaged Foods subindustry, Jia Jie Biomedical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jia Jie Biomedical Co 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jia Jie Biomedical Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Jia Jie Biomedical Co's 5-Year Yield-on-Cost % falls into.
Jia Jie Biomedical Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Jia Jie Biomedical Co (ROCO:4109) has a 5-Year Yield-on-Cost % of 4.44 as of Sep. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Jia Jie Biomedical Co and its competitors. This is 331% above median its historical median of 1.03. Over the past decade, Jia Jie Biomedical Co's 5-Year Yield-on-Cost % has ranged from 0.41 to 4.52. According to the industry distribution chart, Jia Jie Biomedical Co ranks #448 out of 1152 companies in the Consumer Packaged Goods industry, placing it in the top 38.9%.
Is Jia Jie Biomedical Co's 5-Year Yield-on-Cost % too high?
Jia Jie Biomedical Co's current 5-Year Yield-on-Cost % of 4.44 is 331% above median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 4.52. The Consumer Packaged Goods industry median 5-Year Yield-on-Cost % is 3.37. Jia Jie Biomedical Co's value of 4.44 is 31.8% above this industry median. Based on the distribution chart, Jia Jie Biomedical Co ranks #448 out of 1152 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Jia Jie Biomedical Co has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jia Jie Biomedical Co's 5-Year Yield-on-Cost % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Jia Jie Biomedical Co ranks #448 out of 1152 companies for 5-Year Yield-on-Cost %. This puts Jia Jie Biomedical Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 3.37. Jia Jie Biomedical Co's value of 4.44 is 31.8% above this benchmark. Historically, Jia Jie Biomedical Co's own 5-Year Yield-on-Cost % has ranged from 0.41 to 4.52 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 3.37, Jia Jie Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.37, based on 1,152 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jia Jie Biomedical Co's current 5-Year Yield-on-Cost % of 4.44 is 31.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Jia Jie Biomedical Co and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jia Jie Biomedical Co's current 5-Year Yield-on-Cost % is 4.44, which is 331% above median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jia Jie Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Jia Jie Biomedical Co (ROCO:4109) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$16.00, compared to a current price of NT$11.20 — trading 30% below its estimated fair value. The current 5-Year Yield-on-Cost % is 4.44, which is 331% above median its 10-year median of 1.03 and 31.8% above the Consumer Packaged Goods industry median of 3.37. Jia Jie Biomedical Co's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Jia Jie Biomedical Co (ROCO:4109), the current 5-Year Yield-on-Cost % is 4.44 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jia Jie Biomedical Co (ROCO:4109) Overvalued in 2026?
Based on GuruFocus' analysis, Jia Jie Biomedical Co stock appears to be undervalued.
The current stock price of NT$11.20 is trading 30% below its estimated GF Value™ of NT$16.00.
GuruFocus considers Jia Jie Biomedical Co to be Significantly Undervalued.
Key valuation signals for ROCO:4109:
5-Year Yield-on-Cost %: 4.44 (331% above median its 10-year median of 1.03)
GF Value™: NT$16.00 vs. price of NT$11.20 (30% below fair value)
Industry Position: 31.8% above the Consumer Packaged Goods median (#448 of 1152)
No single metric tells the full story. See the ROCO:4109 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
59GF Score
Get the complete analysis for ROCO:4109
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4109 has been successfully added to your 
